6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2’H-spiro[cyclohexane-1,3′-imidazo[1,5a]pyridine]-1′,5′-dione hydrochloride | |
---|---|
Trade Name | |
Orphan Indication | Diffuse Large B-cell Lymphoma |
USA Market Approval | USA |
USA Designation Date | 2017-02-23 00:00:00 |
Sponsor | eFFECTOR Therapeutics;11180 Roselle Street, Suite A;San Diego, California, 92121 |